4//SEC Filing
Hussain Abbas 4
Accession 0001127602-24-025227
CIK 0001682852other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 8:52 AM ET
Size
12.0 KB
Accession
0001127602-24-025227
Insider Transaction Report
Form 4
Moderna, Inc.MRNA
Hussain Abbas
Director
Transactions
- Award
Restricted Stock Units
2024-10-02+892→ 892 total→ Common Stock (892 underlying) - Award
Stock Option (Right to Buy)
2024-10-02+8,093→ 8,093 totalExercise: $63.16Exp: 2034-10-02→ Common Stock (8,093 underlying) - Award
Restricted Stock Units
2024-10-02+1,439→ 1,439 total→ Common Stock (1,439 underlying) - Award
Stock Option (Right to Buy)
2024-10-02+5,100→ 5,100 totalExercise: $63.16Exp: 2034-10-02→ Common Stock (5,100 underlying)
Footnotes (5)
- [F1]This option will become fully vested and exercisable on October 2, 2025.
- [F2]This option will become fully vested and exercisable on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.
- [F3]Restricted stock units convert into common stock on a one-for-one basis.
- [F4]The shares subject to this restricted stock unit award will vest in full on October 2, 2025.
- [F5]The shares subject to this restricted stock unit award will vest in full on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.
Documents
Issuer
Moderna, Inc.
CIK 0001682852
Entity typeother
Related Parties
1- filerCIK 0001821956
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 8:52 AM ET
- Size
- 12.0 KB